A Study to Look at Day to Day Changes in Lung Function in COPD Subjects Taking Albuterol/Salbutamol and Ipratropium

NCT01691482 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

56

Enrollment

INDUSTRY

Sponsor class

Conditions

Pulmonary Disease, Chronic Obstructive

Interventions

DRUG: Albuterol/salbutamol
DRUG: Ipratropium

Sponsor

GlaxoSmithKline